Markus Obermueller
Medical University of Vienna
9 Papers
25 Citations
Markus Obermueller is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Vancomycin & Staphylococcus aureus. The author has an hindex of 4, co-authored 7 publications.
Chat about Author
Papers
Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis.
Manuel Kussmann,Matthias Karer,Markus Obermueller,Katy Schmidt,Wolfgang Barousch,Doris Moser,Marion Nehr,Michael Ramharter,Michael Ramharter,Wolfgang Poeppl,Athanasios Makristathis,Stefan Winkler,Florian Thalhammer,Heinz Burgmann,Heimo Lagler +14 more
TL;DR: For the first time, in vivo induced dalbavancin non-susceptible/teicoplanin resistant, but vancomycin and daptomycin susceptible S. aureus SCVs are demonstrated, indicating the emergence of a novel lipoglycopeptide resistance mechanism.
59
Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model.
Manuel Kussmann,Markus Obermueller,Florian Berndl,Veronika Reischer,Luzia Veletzky,Heinz Burgmann,Wolfgang Poeppl +6 more
TL;DR: Monotherapy with dalbavancin was shown to be as effective as vancomycin for treatment of experimental implant-related MRSA osteomyelitis in rats, but both antimicrobials demonstrated only limited efficacy.
Different Types of Coagulase Are Associated With 28-Day Mortality in Patients With Staphylococcus aureus Bloodstream Infections
Matthias Karer,Manuel Kussmann,Franz Ratzinger,Markus Obermueller,Veronika Reischer,Heidemarie Winkler,Richard Kriz,Heinz Burgmann,Bernd Jilma,Heimo Lagler +9 more
TL;DR: An association of coagulase gene size and fib regarding 28-day mortality was observed in patients with S. aureus bloodstream infections, based on the data obtained in the present study.
Synergistic Effect of Cefazolin Plus Fosfomycin Against Staphylococcus aureus in vitro and in vivo in an Experimental Galleria mellonella Model.
Manuel Kussmann,Markus Obermueller,Matthias Karer,Richard Kriz,Rui-Yang Chen,Lena Hohl,Lisa Schneider,Heinz Burgmann,Ludwig Traby,Matthias G. Vossen +9 more
TL;DR: In this paper, the authors investigated the synergistic in vitro and in vivo activity of cefazolin plus fosfomycin against methicillin-resistant S. aureus (MSSA) and MRSA.
Biomarkers for differentiation of coronavirus disease 2019 or extracorporeal membrane oxygenation related inflammation and bacterial/fungal infections in critically ill patients: A prospective observational study
Matthias Weiss-Tessbach,Franz Ratzinger,Markus Obermueller,Heinz Burgmann,Thomas Staudinger,Oliver Robak,Monika Schmid,Bernhard Roessler,Bernd Jilma,Manuel Kussmann,Ludwig Traby +10 more
TL;DR: The present study highlights the use of IL-10 to differentiate secondary bacterial/fungal infections from CO VID-19 and/or ECMO associated inflammation in severely ill COVID-19 patients.